Comparison of AMG 416 and cinacalcet in rodent models of uremia

BACKGROUND: AMG 416 is a novel peptide agonist of the calcium-sensing receptor (CaSR). This report describes the activity of AMG 416 in two different rodent models of uremia, compared in each case to cinacalcet, an approved therapeutic for secondary hyperparathyroidism (SHPT) in patients with chroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Sarah, Baruch, Amos, Alexander, Shawn T, Janes, Julie, Sho, Eiketsu, Dong, Jin, Yin, Qun, Maclean, Derek, Mendel, Dirk B, Karim, Felix, Johnson, Randolph M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030018/
https://www.ncbi.nlm.nih.gov/pubmed/24884838
http://dx.doi.org/10.1186/1471-2369-15-81

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030018/
https://www.ncbi.nlm.nih.gov/pubmed/24884838
http://dx.doi.org/10.1186/1471-2369-15-81

Ejemplares similares